Global Insulin Glargine Market Research Report 2023

Report ID: 1638188 | Published Date: Sep 2024 | No. of Page: 92 | Base Year: 2023 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Insulin Glargine Market Overview
    1.1 Product Overview and Scope of Insulin Glargine
    1.2 Insulin Glargine Segment by Type
        1.2.1 Global Insulin Glargine Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Prefilled Injection
        1.2.3 Non-Prefilled Injection
    1.3 Insulin Glargine Segment by Application
        1.3.1 Global Insulin Glargine Sales Comparison by Application: (2022-2028)
        1.3.2 Type 1 Diabetes Treatment
        1.3.3 Type 2 Diabetes Treatment
    1.4 Global Insulin Glargine Market Size Estimates and Forecasts
        1.4.1 Global Insulin Glargine Revenue 2017-2028
        1.4.2 Global Insulin Glargine Sales 2017-2028
        1.4.3 Insulin Glargine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Insulin Glargine Market Competition by Manufacturers
    2.1 Global Insulin Glargine Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Insulin Glargine Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Insulin Glargine Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Insulin Glargine Manufacturing Sites, Area Served, Product Type
    2.5 Insulin Glargine Market Competitive Situation and Trends
        2.5.1 Insulin Glargine Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Insulin Glargine Players Market Share by Revenue
        2.5.3 Global Insulin Glargine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Insulin Glargine Retrospective Market Scenario by Region
    3.1 Global Insulin Glargine Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Insulin Glargine Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Insulin Glargine Market Facts & Figures by Country
        3.3.1 North America Insulin Glargine Sales by Country
        3.3.2 North America Insulin Glargine Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Insulin Glargine Market Facts & Figures by Country
        3.4.1 Europe Insulin Glargine Sales by Country
        3.4.2 Europe Insulin Glargine Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Insulin Glargine Market Facts & Figures by Region
        3.5.1 Asia Pacific Insulin Glargine Sales by Region
        3.5.2 Asia Pacific Insulin Glargine Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Insulin Glargine Market Facts & Figures by Country
        3.6.1 Latin America Insulin Glargine Sales by Country
        3.6.2 Latin America Insulin Glargine Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Insulin Glargine Market Facts & Figures by Country
        3.7.1 Middle East and Africa Insulin Glargine Sales by Country
        3.7.2 Middle East and Africa Insulin Glargine Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Insulin Glargine Historic Market Analysis by Type
    4.1 Global Insulin Glargine Sales Market Share by Type (2017-2022)
    4.2 Global Insulin Glargine Revenue Market Share by Type (2017-2022)
    4.3 Global Insulin Glargine Price by Type (2017-2022)
5 Global Insulin Glargine Historic Market Analysis by Application
    5.1 Global Insulin Glargine Sales Market Share by Application (2017-2022)
    5.2 Global Insulin Glargine Revenue Market Share by Application (2017-2022)
    5.3 Global Insulin Glargine Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Sanofi
        6.1.1 Sanofi Corporation Information
        6.1.2 Sanofi Description and Business Overview
        6.1.3 Sanofi Insulin Glargine Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Sanofi Insulin Glargine Product Portfolio
        6.1.5 Sanofi Recent Developments/Updates
    6.2 Eli Lilly
        6.2.1 Eli Lilly Corporation Information
        6.2.2 Eli Lilly Description and Business Overview
        6.2.3 Eli Lilly Insulin Glargine Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Eli Lilly Insulin Glargine Product Portfolio
        6.2.5 Eli Lilly Recent Developments/Updates
    6.3 Viatris
        6.3.1 Viatris Corporation Information
        6.3.2 Viatris Description and Business Overview
        6.3.3 Viatris Insulin Glargine Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Viatris Insulin Glargine Product Portfolio
        6.3.5 Viatris Recent Developments/Updates
    6.4 Gan&Lee Pharmaceuticals
        6.4.1 Gan&Lee Pharmaceuticals Corporation Information
        6.4.2 Gan&Lee Pharmaceuticals Description and Business Overview
        6.4.3 Gan&Lee Pharmaceuticals Insulin Glargine Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Gan&Lee Pharmaceuticals Insulin Glargine Product Portfolio
        6.4.5 Gan&Lee Pharmaceuticals Recent Developments/Updates
    6.5 Tonghua Dongbao Pharmaceutical
        6.5.1 Tonghua Dongbao Pharmaceutical Corporation Information
        6.5.2 Tonghua Dongbao Pharmaceutical Description and Business Overview
        6.5.3 Tonghua Dongbao Pharmaceutical Insulin Glargine Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Tonghua Dongbao Pharmaceutical Insulin Glargine Product Portfolio
        6.5.5 Tonghua Dongbao Pharmaceutical Recent Developments/Updates
    6.6 United Laboratories International
        6.6.1 United Laboratories International Corporation Information
        6.6.2 United Laboratories International Description and Business Overview
        6.6.3 United Laboratories International Insulin Glargine Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 United Laboratories International Insulin Glargine Product Portfolio
        6.6.5 United Laboratories International Recent Developments/Updates
7 Insulin Glargine Manufacturing Cost Analysis
    7.1 Insulin Glargine Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Insulin Glargine
    7.4 Insulin Glargine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Insulin Glargine Distributors List
    8.3 Insulin Glargine Customers
9 Insulin Glargine Market Dynamics
    9.1 Insulin Glargine Industry Trends
    9.2 Insulin Glargine Market Drivers
    9.3 Insulin Glargine Market Challenges
    9.4 Insulin Glargine Market Restraints
10 Global Market Forecast
    10.1 Insulin Glargine Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Insulin Glargine by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Insulin Glargine by Type (2023-2028)
    10.2 Insulin Glargine Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Insulin Glargine by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Insulin Glargine by Application (2023-2028)
    10.3 Insulin Glargine Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Insulin Glargine by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Insulin Glargine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Insulin Glargine Sales Growth Rate Comparison by Type (2022-2028) & (M mL) & (US$ Million)
    Table 2. Global Insulin Glargine Sales Growth Rate Comparison by Application (2022-2028) & (M mL) & (US$ Million)
    Table 3. Global Insulin Glargine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Insulin Glargine Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Insulin Glargine Sales (M mL) of Key Manufacturers (2017-2022)
    Table 6. Global Insulin Glargine Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Insulin Glargine Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Insulin Glargine Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Insulin Glargine Average Price (USD/mL) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Insulin Glargine Manufacturing Sites and Area Served
    Table 11. Manufacturers Insulin Glargine Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Insulin Glargine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin Glargine as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Insulin Glargine Sales by Region (2017-2022) & (M mL)
    Table 16. Global Insulin Glargine Sales Market Share by Region (2017-2022)
    Table 17. Global Insulin Glargine Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Insulin Glargine Revenue Market Share by Region (2017-2022)
    Table 19. North America Insulin Glargine Sales by Country (2017-2022) & (M mL)
    Table 20. North America Insulin Glargine Sales Market Share by Country (2017-2022)
    Table 21. North America Insulin Glargine Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Insulin Glargine Revenue Market Share by Country (2017-2022)
    Table 23. Europe Insulin Glargine Sales by Country (2017-2022) & (M mL)
    Table 24. Europe Insulin Glargine Sales Market Share by Country (2017-2022)
    Table 25. Europe Insulin Glargine Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Insulin Glargine Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Insulin Glargine Sales by Region (2017-2022) & (M mL)
    Table 28. Asia Pacific Insulin Glargine Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Insulin Glargine Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Insulin Glargine Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Insulin Glargine Sales by Country (2017-2022) & (M mL)
    Table 32. Latin America Insulin Glargine Sales Market Share by Country (2017-2022)
    Table 33. Latin America Insulin Glargine Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Insulin Glargine Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Insulin Glargine Sales by Country (2017-2022) & (M mL)
    Table 36. Middle East and Africa Insulin Glargine Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Insulin Glargine Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Insulin Glargine Revenue Market Share by Country (2017-2022)
    Table 39. Global Insulin Glargine Sales by Type (2017-2022) & (M mL)
    Table 40. Global Insulin Glargine Sales Market Share by Type (2017-2022)
    Table 41. Global Insulin Glargine Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Insulin Glargine Revenue Share by Type (2017-2022)
    Table 43. Global Insulin Glargine Price by Type (2017-2022) & (USD/mL)
    Table 44. Global Insulin Glargine Sales (M mL) by Application (2017-2022)
    Table 45. Global Insulin Glargine Sales Market Share by Application (2017-2022)
    Table 46. Global Insulin Glargine Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Insulin Glargine Revenue Share by Application (2017-2022)
    Table 48. Global Insulin Glargine Price by Application (2017-2022) & (USD/mL)
    Table 49. Sanofi Corporation Information
    Table 50. Sanofi Description and Business Overview
    Table 51. Sanofi Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022)
    Table 52. Sanofi Insulin Glargine Product
    Table 53. Sanofi Recent Developments/Updates
    Table 54. Eli Lilly Corporation Information
    Table 55. Eli Lilly Description and Business Overview
    Table 56. Eli Lilly Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022)
    Table 57. Eli Lilly Insulin Glargine Product
    Table 58. Eli Lilly Recent Developments/Updates
    Table 59. Viatris Corporation Information
    Table 60. Viatris Description and Business Overview
    Table 61. Viatris Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022)
    Table 62. Viatris Insulin Glargine Product
    Table 63. Viatris Recent Developments/Updates
    Table 64. Gan&Lee Pharmaceuticals Corporation Information
    Table 65. Gan&Lee Pharmaceuticals Description and Business Overview
    Table 66. Gan&Lee Pharmaceuticals Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022)
    Table 67. Gan&Lee Pharmaceuticals Insulin Glargine Product
    Table 68. Gan&Lee Pharmaceuticals Recent Developments/Updates
    Table 69. Tonghua Dongbao Pharmaceutical Corporation Information
    Table 70. Tonghua Dongbao Pharmaceutical Description and Business Overview
    Table 71. Tonghua Dongbao Pharmaceutical Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022)
    Table 72. Tonghua Dongbao Pharmaceutical Insulin Glargine Product
    Table 73. Tonghua Dongbao Pharmaceutical Recent Developments/Updates
    Table 74. United Laboratories International Corporation Information
    Table 75. United Laboratories International Description and Business Overview
    Table 76. United Laboratories International Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022)
    Table 77. United Laboratories International Insulin Glargine Product
    Table 78. United Laboratories International Recent Developments/Updates
    Table 79. Production Base and Market Concentration Rate of Raw Material
    Table 80. Key Suppliers of Raw Materials
    Table 81. Insulin Glargine Distributors List
    Table 82. Insulin Glargine Customers List
    Table 83. Insulin Glargine Market Trends
    Table 84. Insulin Glargine Market Drivers
    Table 85. Insulin Glargine Market Challenges
    Table 86. Insulin Glargine Market Restraints
    Table 87. Global Insulin Glargine Sales Forecast by Type (2023-2028) & (M mL)
    Table 88. Global Insulin Glargine Sales Market Share Forecast by Type (2023-2028)
    Table 89. Global Insulin Glargine Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 90. Global Insulin Glargine Revenue Market Share Forecast by Type (2023-2028)
    Table 91. Global Insulin Glargine Sales Forecast by Application (2023-2028) & (M mL)
    Table 92. Global Insulin Glargine Sales Market Share Forecast by Application (2023-2028)
    Table 93. Global Insulin Glargine Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 94. Global Insulin Glargine Revenue Market Share Forecast by Application (2023-2028)
    Table 95. Global Insulin Glargine Sales Forecast by Region (2023-2028) & (M mL)
    Table 96. Global Insulin Glargine Sales Market Share Forecast by Region (2023-2028)
    Table 97. Global Insulin Glargine Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 98. Global Insulin Glargine Revenue Market Share Forecast by Region (2023-2028)
    Table 99. Research Programs/Design for This Report
    Table 100. Key Data Information from Secondary Sources
    Table 101. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Insulin Glargine
    Figure 2. Global Insulin Glargine Market Share by Type in 2021 & 2028
    Figure 3. Prefilled Injection Product Picture
    Figure 4. Non-Prefilled Injection Product Picture
    Figure 5. Global Insulin Glargine Market Share by Application in 2021 & 2028
    Figure 6. Type 1 Diabetes Treatment
    Figure 7. Type 2 Diabetes Treatment
    Figure 8. Global Insulin Glargine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 9. Global Insulin Glargine Market Size (2017-2028) & (US$ Million)
    Figure 10. Global Insulin Glargine Sales (2017-2028) & (M mL)
    Figure 11. Insulin Glargine Sales Share by Manufacturers in 2021
    Figure 12. Global Insulin Glargine Revenue Share by Manufacturers in 2021
    Figure 13. The Global 5 and 10 Largest Insulin Glargine Players: Market Share by Revenue in 2021
    Figure 14. Insulin Glargine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 15. Global Insulin Glargine Sales Market Share by Region (2017-2022)
    Figure 16. Global Insulin Glargine Sales Market Share by Region in 2021
    Figure 17. Global Insulin Glargine Revenue Market Share by Region (2017-2022)
    Figure 18. Global Insulin Glargine Revenue Market Share by Region in 2021
    Figure 19. U.S. Insulin Glargine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 20. Canada Insulin Glargine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Germany Insulin Glargine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. France Insulin Glargine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. U.K. Insulin Glargine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Italy Insulin Glargine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Russia Insulin Glargine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. China Insulin Glargine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Japan Insulin Glargine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. South Korea Insulin Glargine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. India Insulin Glargine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Australia Insulin Glargine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. China Taiwan Insulin Glargine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Indonesia Insulin Glargine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Thailand Insulin Glargine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Malaysia Insulin Glargine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Mexico Insulin Glargine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Brazil Insulin Glargine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Argentina Insulin Glargine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Turkey Insulin Glargine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Saudi Arabia Insulin Glargine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. UAE Insulin Glargine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Sales Market Share of Insulin Glargine by Type (2017-2022)
    Figure 42. Manufacturing Cost Structure of Insulin Glargine
    Figure 43. Manufacturing Process Analysis of Insulin Glargine
    Figure 44. Insulin Glargine Industrial Chain Analysis
    Figure 45. Channels of Distribution
    Figure 46. Distributors Profiles
    Figure 47. Bottom-up and Top-down Approaches for This Report
    Figure 48. Data Triangulation
    Figure 49. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi
Eli Lilly
Viatris
Gan&Lee Pharmaceuticals
Tonghua Dongbao Pharmaceutical
United Laboratories International
Frequently Asked Questions
Insulin Glargine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Insulin Glargine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Insulin Glargine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports